Last 47 quarters of trend data · Healthcare · Medical - Distribution
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 31.58 | 35.14 | 31.26 | 26.08 | 20.87 | 42.00 | 16.40 | 17.92 | 16.25 | 25.60 | 26.14 | 16.80 | 1085.25 | — | 14.09 | — | 41.68 | 26.14 | — | 75.72 | 13.15 |
| — | -16.3% | +90.6% | +45.5% | +28.4% | +64.0% | -37.3% | +6.7% | -98.5% | — | +85.6% | — | +2504.1% | — | — | — | +216.8% | -26.8% | — | +1104.5% | — | |
| P/S Ratio | 0.21 | 0.22 | 0.20 | 0.19 | 0.15 | 0.17 | 0.15 | 0.13 | 0.13 | 0.10 | 0.12 | 0.11 | 0.10 | 0.11 | 0.10 | 0.10 | 0.09 | 0.08 | 0.09 | 0.08 | 0.08 |
| — | +31.5% | +35.3% | +43.1% | +13.1% | +66.1% | +21.1% | +20.5% | +30.4% | -10.2% | +29.5% | +10.7% | +8.2% | +47.3% | +10.9% | +22.5% | +12.9% | -22.3% | -23.5% | -16.3% | -7.7% | |
| P/B Ratio | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 14.44 | 10.24 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | +80.5% | +6.1% | |
| P/FCF | 11.82 | 9.86 | 7.43 | 21.94 | 10.84 | 7.78 | 2.97 | — | — | 3.20 | — | 5.82 | 12.45 | 9.37 | 3.89 | 9.80 | — | 1.27 | — | 3.23 | — |
| — | +26.6% | +150.0% | — | — | +143.5% | — | — | — | -65.9% | — | -40.6% | — | +637.3% | — | +203.6% | — | -83.6% | — | -8.4% | — | |
| EV / EBITDA | 16.41 | 14.77 | 18.11 | 15.76 | 11.64 | 17.97 | 10.02 | 10.98 | 9.79 | 10.34 | 13.53 | 9.16 | 40.23 | 19.69 | 6.77 | 106.23 | 16.22 | 17.41 | 56.10 | — | 7.50 |
| — | -17.8% | +80.8% | +43.5% | +18.9% | +73.8% | -25.9% | +19.8% | -75.7% | -47.5% | +99.9% | -91.4% | +148.1% | +13.1% | -87.9% | — | +116.3% | +21.8% | +614.9% | — | — | |
| EV / EBIT | 80.33 | 18.97 | 27.81 | 25.35 | 15.47 | 25.00 | 12.70 | 14.90 | 12.82 | 15.67 | 19.97 | 12.10 | — | 45.30 | 8.84 | — | 37.00 | 623.84 | — | — | 10.69 |
| — | -24.1% | +118.9% | +70.1% | +20.7% | +59.5% | -36.4% | +23.1% | — | -65.4% | +125.9% | — | — | -92.7% | — | — | +246.2% | +1979.9% | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 3.8% | 4.3% | 4.1% | 3.4% | 3.6% | 3.7% | 3.9% | 3.5% | 3.6% | 3.1% | 3.5% | 3.2% | 3.2% | 3.4% | 3.5% | 3.2% | 3.3% | 3.4% | 3.8% | 3.6% | 3.7% |
| — | +17.5% | +6.0% | -3.8% | -0.4% | +17.9% | +9.7% | +9.3% | +14.1% | -9.2% | -0.3% | -0.5% | -2.0% | +0.3% | -5.8% | -9.1% | -12.9% | -1.6% | -18.7% | -16.8% | -14.9% | |
| Operating Margin | 1.0% | 1.1% | 0.8% | 1.1% | 1.0% | 0.7% | 1.3% | 1.0% | 1.1% | 0.7% | 0.7% | 0.9% | -0.1% | 0.3% | 1.1% | -0.2% | 0.3% | 0.1% | -0.2% | -2.1% | 0.9% |
| — | +60.5% | -37.2% | +8.8% | -3.9% | +4.1% | +97.8% | +13.0% | +1954.1% | +166.6% | -40.6% | +480.2% | -121.2% | +235.5% | +623.8% | +88.9% | -70.7% | -79.9% | -118.0% | -288.3% | +159.1% | |
| Net Margin | 0.7% | 0.6% | 0.7% | 0.7% | 0.7% | 0.4% | 0.9% | 0.7% | 0.8% | 0.4% | 0.5% | 0.6% | -0.0% | -0.1% | 0.7% | -0.3% | 0.2% | 0.3% | -3.1% | 0.1% | 0.6% |
| — | +55.3% | -29.0% | -0.6% | -11.7% | +0.5% | +93.8% | +13.0% | +3717.3% | +430.2% | -30.4% | +353.6% | -109.9% | -140.9% | +122.0% | -334.3% | -64.0% | +7.6% | -1123.2% | -92.9% | +195.2% |
| Metric | TTM | Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | -899.7% | 4.1% | 17.0% |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | -14347.3% | -89.0% | +208.0% | |
| ROA | 3.0% | 0.7% | 0.7% | 0.8% | 0.8% | 0.5% | 1.0% | 0.9% | 0.9% | 0.5% | 0.6% | 0.8% | -0.0% | -0.1% | 0.8% | -0.3% | 0.3% | 0.3% | -3.2% | 0.1% | 0.6% |
| — | +49.0% | -33.4% | -6.4% | -12.0% | -10.5% | +85.0% | +9.0% | +3518.5% | +451.4% | -28.1% | +375.5% | -110.9% | -146.0% | +124.2% | -361.6% | -59.3% | +22.2% | -1306.4% | -92.2% | +201.0% | |
| ROIC | 82.8% | 23.4% | 13.0% | 20.2% | 22.0% | 12.1% | 32.9% | 47.1% | — | — | — | — | — | — | — | — | — | 2.2% | -2.4% | -17.7% | 6.8% |
| — | +92.8% | -60.4% | -57.1% | — | — | — | — | — | — | — | — | — | — | — | — | — | -12.7% | -133.9% | -365.3% | +181.0% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 5.63 | 4.05 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | +65.2% | -14.4% | |
| Debt / EBITDA | 2.79 | 9.57 | 11.78 | 10.35 | 10.02 | 14.67 | 8.20 | 10.26 | 6.89 | 9.44 | 10.72 | 6.95 | 33.41 | 15.02 | 6.34 | 103.18 | 17.10 | 24.72 | 66.81 | — | 9.70 |
| — | -34.7% | +43.7% | +0.9% | +45.6% | +55.4% | -23.6% | +47.8% | -79.4% | -37.1% | +69.2% | -93.3% | +95.4% | -39.2% | -90.5% | — | +76.3% | +35.6% | +567.0% | — | — | |
| Current Ratio | 0.88 | 0.88 | 0.91 | 0.91 | 0.96 | 0.94 | 0.94 | 1.02 | 0.95 | 0.98 | 0.98 | 0.98 | 0.99 | 1.00 | 1.03 | 1.04 | 1.04 | 1.08 | 1.08 | 1.15 | 1.12 |
| — | -5.6% | -3.9% | -10.8% | +0.9% | -4.5% | -4.1% | +3.2% | -4.1% | -2.1% | -4.5% | -5.6% | -4.5% | -7.2% | -4.2% | -9.3% | -7.7% | -4.1% | -10.3% | -1.8% | -0.3% | |
| Quick Ratio | 0.49 | 0.49 | 0.48 | 0.44 | 0.52 | 0.50 | 0.50 | 0.54 | 0.50 | 0.56 | 0.51 | 0.50 | 0.50 | 0.52 | 0.52 | 0.52 | 0.53 | 0.57 | 0.54 | 0.61 | 0.57 |
| — | -2.7% | -5.0% | -17.5% | +4.5% | -10.1% | -1.1% | +6.7% | -1.3% | +7.1% | -2.1% | -3.9% | -5.2% | -7.8% | -3.1% | -14.4% | -6.0% | -4.9% | -15.3% | +0.2% | +0.1% | |
| Interest Coverage | 7.25 | 10.24 | 4.88 | 6.16 | 8.47 | 6.19 | 9.99 | 15.60 | 17.91 | 98.00 | 13.21 | 171.67 | -3.00 | 9.07 | 20.43 | -4.48 | 5.40 | 0.18 | -2.61 | -25.30 | 10.22 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 47 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying CAH stock.
Cardinal Health, Inc.'s current P/E is 31.6x. The average P/E over the last 4 quarters is 28.3x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Cardinal Health, Inc.'s current operating margin is 1.0%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Cardinal Health, Inc.'s business trajectory between earnings reports.